Glaucoma Now is a 12 to 16-page, newsletter-format, enduring material published two times each year. Each issue has a major theme. Within each issue there are four sections, each of which treats some aspect of the theme in a predefined way.
Each issue also includes a list of multiple choice questions related to the contents of the 4 sections.
Special Focus: A comprehensive overview of basic science understanding of glaucoma including mechanisms of damage, cellular effects in neurodegeneration (oxidative stress, protein misfolding, mitochondrial dysfunction), risk factors, parameters measured ( IOP, CCT, OPP, changes in optic disc and OCT findings, electrophysiology PERG/VEP, VF ), outlook and implications.
What’s New: A discussion of why early glaucoma diagnosis is so important, including risk assessment and parameters of detection (RNFL abnormalities, electrophysiology, VF defects) summarizing existing gold standards and giving an outlook on new technologies
Clinical Issues: A review of current techniques in monitoring glaucoma progression, including gold standard HRT, other approaches such as OCT, GDx, PERG/VEP and long-term data
Practical Tips: A summary on all options to manage glaucoma in pregnancy and lactation
Access the latest issue of Glaucoma Now. Each issue focuses on a major theme and is split into four sections: Special Focus, What's New, Clinical Issues and Practical Tips.
Based on the information found in each electronic issue, we offer an associated e-learning course. Individual issues of Glaucoma Now are accredited for Continuing Medical Education (CME).
About Glaucoma Now
Our goal is to educate and update general ophthalmologists, glaucoma specialists and ophthalmology residents. Learn more about our publication, guidelines for authors and our editorial board.
Ivan Goldberg MD, FRANZCO, FRACS, Sydney Eye Hospital, Sydney, NSW, Australia
Remo Susanna Jr MD, Department of Ophthalmology, University of São Paulo, São Paulo, Brazil